Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Topical finasteride effectively and safely increases hair growth in men with hair loss.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

The two lotions used day and night may be a good alternative to minoxidil for hair loss treatment with better cosmetic effects and tolerance.

Topical finasteride is an effective and safer treatment for male hair loss.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Tralokinumab for atopic dermatitis may cause side effects like dizziness, headache, nausea, hair loss, and acne.

Dutasteride 0.5 mg daily improves hair growth safely in men with hair loss.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Baricitinib is effective and safe for treating severe alopecia areata.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.